Health and Wellness After Preterm Birth
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Feb 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Health and Wellness After Preterm Birth," is looking at ways to improve health and well-being for women who have given birth prematurely. The study is testing a program called Care Coordination After Preterm Birth (CCAPB), which aims to help women manage their health after having a baby born before 37 weeks of pregnancy. Researchers want to see how effective this program is in addressing issues like using healthcare services, tobacco use, depression, and other health factors.
To join the study, women need to be between 14 and 45 years old, have a history of preterm birth, and plan to seek pediatric care for their child at specific clinics. They should also have Medicaid insurance. Participants will receive support through the CCAPB program and will be assessed before and after the intervention to see how it helps improve their health. It’s important to note that some women may not be eligible if they have had certain medical procedures or plan to move away soon. This study aims to provide valuable insights into better care for women and their families after preterm births.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Age 14 - 45
- • History of preterm birth (\< 34 weeks gestational age or 34 - 36 weeks with identifiable risk factors for recurrent preterm birth which may including: low preventive care utilization, tobacco use, obesity, depression or anxiety, history of unmet contraceptive needs, chronic or pregnancy-associated hypertension or diabetes. )
- • Intention to seek pediatric care at one of two pediatric primary care sites
- • Medicaid insurance
- Exclusion Criteria:
- • History of sterilization procedure.
- • Plan to move away from the area or transfer pediatric primary care within six months of enrollment.
- • Limited English proficiency.
- • History of organ failure or malignancies.
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Emily Gregory, MD, MPH
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials